InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Estepan Ian Michael, Chief Financial Officer. Officer active across 1 companies, notably Sarepta Therapeutics, Inc.. Aggregated, 4 filings have been published. The latest transaction was disclosed on 4 March 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
€93,6071,308 shares@ €71.56510.0041% mcap28.0% of flow
Common Stock
SEC:0001209191-22-017347:0·
€25,160376 shares@ €66.91380.0011% mcap7.5% of flow
Common Stock
SEC:0001209191-22-014408:0·
€107,5081,623 shares@ €66.2402100.0% of flow
Common Stock
SEC:0001209191-21-055383·
€107,5081,623 shares@ €66.24020.0048% mcap32.2% of flow
Common Stock
SEC:0001209191-21-055383:0·
4 of 4 declarations
About Estepan Ian Michael
Estepan Ian Michael is the Chief Financial Officer of Sarepta Therapeutics, Inc. He is responsible for the financial management of the company, including budget planning and risk management. His expertise in finance is crucial to support the company's growth and profitability.
